Option Care Health (OPCH) Could Be 27% Undervalued After Q2 Results And Guidance
Option Care Health Inc OPCH
$23.03
β² +2.54%
(+$0.57)
Open
$22.32
Prev Close
$22.46
Day Range
$22.29 β $23.09
52W Range
$18.01 β $36.80
Market Cap
$3.62B
P/E (TTM)
17.54
Beta
0.60
EPS (TTM)
$1.28
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1996-08-15 |
| Shares Out. | 149,790,000 |
| Website | optioncarehealth.com/ β |
| Phone | 13026365400 |
| Employees | 8,266 |
| Revenue | $1.44B |
| Gross Profit | $267.3M |
| Net Income | $53.9M |
| Free Cash Flow | $303.8M |
| Total Assets | $3.38B |
| Total Liabilities | $2.12B |
| Equity | $1.26B |
About Option Care Health Inc
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
Option Care Health Inc is a publicly traded company under the ticker symbol OPCH on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
19 analysts (2026-07-01)
π° Latest News for OPCH
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24
Option Care Health Inc (OPCH) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Option Care Health, Inc. Q2 2026 Earnings Call Summary
Option Care Health Q2 Earnings Call Highlights
Option Care Health, Inc. (OPCH) Q2 2026 Earnings Call Transcript
Option Care Health (NASDAQ:OPCH) Beats Q2 Earnings Estimates, Shares Rise on Strong Cash Flow and Buybacks
Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates

